Medical Equipment

Global Lipid Panel Testing Market Set for Strong Expansion Reaching $17.79 Billion by 2030 at 9% CAGR

March 13, 2026March 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Lipid Panel Testing Market By 2030 Starting From Its 2026 Size?

The lipid panel testing market has demonstrated significant growth in recent years. It is anticipated to expand from $11.61 billion in 2025 to $12.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The expansion observed in previous periods was largely a result of the increasing occurrence of cardiovascular diseases, the broadening of routine health screening initiatives, heightened awareness regarding cholesterol management, the adoption of automated laboratory diagnostic tools, and enhanced accessibility to diagnostic services.

The lipid panel testing market size is expected to witness strong expansion in the coming years. It is forecast to grow to $17.79 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be attributed to an increased focus on preventive healthcare, rising demand for home diagnostics, the integration of digital health platforms, the growing utilization of AI-assisted diagnostic interpretation, and the expansion of population health screening initiatives. Key trends anticipated in the forecast period involve the increasing adoption of point-of-care lipid testing, a rising use of automated lipid analyzers, growing demand for preventive cardiovascular screening, the expansion of home-based lipid testing kits, and an enhanced focus on early risk assessment.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

What Primary Drivers Are Shaping The Development Of The Lipid Panel Testing Market?

The increasing prevalence of cardiovascular and diabetic conditions is projected to drive expansion in the lipid panel testing market in the future. Cardiovascular diseases encompass various ailments impacting the heart and blood vessels, whereas diabetes is a long-term metabolic disorder marked by high blood sugar levels. Both these health issues substantially elevate lipid irregularities, rendering lipid testing crucial for early diagnosis, risk assessment, therapeutic strategy, and ongoing observation. Lipid panel testing assists medical professionals in detecting dyslipidemia, directing treatment approaches, and mitigating the likelihood of severe complications like heart attacks and strokes. As an illustration, in September 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, reported that worldwide cardiovascular disease fatalities totaled $ 0.0192 billion (19.2 million) in 2023. Consequently, the growing impact of cardiovascular and diabetic conditions is fueling the expansion of the lipid panel testing market.

Which Segment Categories Define The Lipid Panel Testing Market?

The lipid panel testing market covered in this report is segmented –

1) By Product And Services: Devices, Kits, Services

2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing

3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications

4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers

2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits

3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

What Major Market Trends Are Driving Changes In The Lipid Panel Testing Market?

Leading companies in the lipid panel testing market are concentrating on developing sophisticated solutions, such as Lp(a)-based diagnostic assays, to improve cardiovascular risk assessment. An Lp(a)-based assay is a medical test that quantifies the level of lipoprotein(a) in the blood, enabling clinicians to pinpoint individuals with a heightened risk of cardiovascular diseases and provide customized treatment recommendations. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and diagnostics company, introduced the Tina-quant Lp(a) RxDx assay after obtaining FDA Breakthrough Device Designation. This innovation measures the number of Lp(a) molecules per litre in a person’s bloodstream, serving as a standardized and actionable biomarker for cardiovascular risk. Integrated into Roche’s existing serum work area (SWA) systems and cobas® platforms, it empowers healthcare professionals to make informed decisions regarding Lp(a)-lowering therapies, thereby enhancing patient outcomes and supporting precision cardiovascular care. The assay simplifies Lp(a) testing, boosts diagnostic accuracy, and facilitates the wider adoption of personalized lipid management strategies.

Who Are The Top Companies Competing In The Lipid Panel Testing Market?

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

Read the full lipid panel testing market report here:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

How Does The Lipid Panel Testing Market Perform Across Major Global Regions?

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lipid Panel Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10270&type=smp

Browse Through More Reports Similar to the Global Lipid Panel Testing Market 2026, By The Business Research Company

Lipid Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Lipid Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Lipid Regulators Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795